Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
Bayer
Paolo Lanzetta; Jean-François Korobelnik; Jeffrey S Heier; Sergio Leal; Frank G Holz; W Lloyd Clark; David Eichenbaum; Tomohiro Iida; Sun Xiaodong; Alyson J Berliner; Andrea Schulze; Thomas Schmelter; Ursula Schmidt-Ott; Xin Zhang; Robert Vitti; Karen W Chu; Kimberly Reed; Rohini Rao; Rafia Bhore; Yenchieh Cheng; Wei Sun; Boaz Hirshberg; George D Yancopoulos; Tien Y Wong; PULSAR Investigators